| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Pralatrexate | Pralatrexate R-Isomer | VE009484 | View |
| Pralatrexate | 10-Propargyl-4-deoxy-4-amino-10-deazapteroic Acid | VE009450 | View CAS 146464-93-9 |
| Pralatrexate | 4-Hydroxy Pralatrexate | VE009454 | View CAS 1548618-61-6 |
| Catalogue No. | VE009450 |
| CAS No. | 146464-93-9 |
| Molecular Formula | C18H16N6O2 |
| Molecular Weight | 348.36 g/mol |
| Parent drug | Pralatrexate |
| IUPAC Name | 4-[1-[(2, 4-Diamino-6-pteridinyl)methyl]-3-butyn-1-yl]benzoic Acid |
| Synonyms | N/A |
| References | Marchi, Enrica, and Owen A. O’Connor. Safety and Efficacy of Pralatrexate in the Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma.” Therapeutic Advances in Hematology, vol. 3, no. 4, Apr. 2012, pp. 227–35, https://doi.org/10.1177/2040620712445330. |
| Status | In-stock |
| ListName | 10-Propargyl-4-deoxy-4-amino-10-deazapteroic Acid |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
